Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin
Background. Hearing is essential in child development. Cisplatin which is a common chemotherapy used in many pediatric solid-tumor protocols cause various degrees of ototoxicity. Several risk factors for cisplatininduced ototoxicity have been reported, including race and age. This study aimed...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hacettepe University Institute of Child Health
2022-06-01
|
| Serija: | The Turkish Journal of Pediatrics |
| Teme: | |
| Online pristup: | https://turkjpediatr.org/article/view/179 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
